FDA-approved test for routine cervical cancer screening at 3-year intervals in all individuals ≥21 years with a cervix. Acceptable test for routine cervical cancer screening at 3-year intervals in all individuals 25-65 years with a cervix; the preferred test for this group is Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by Nucleic Acid Amplification (NAA), ThinPrep (3003005).
ThinPrep 2000 System/Routine Cytopathologic Evaluation/Microscopy
New York DOH Approval Status
Cervical specimen in a ThinPrep Pap Test collection kit, broom kit (ARUP Supply #12587) or brush/spatula kit (ARUP Supply #40624) available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787. For specific instructions refer to Specimen Collection and Handling.
Transport cervical specimen in the original collection kit.
Specimens not collected in a ThinPrep Pap Test collection kit or specimens submitted in an expired collection kit.
Ambient: 3 weeks; Refrigerated: 3 weeks; Frozen: Unacceptable
Refer to report.
The ThinPrep 2000 System is for use in screening for the presence of atypical cells, cervical cancer, or precursor lesions (LSIL, HSIL) as well as other cytologic categories as defined by the Bethesda System for Reporting Cervical Cytology, and is intended as a replacement for the conventional method of Pap smears.
The Pap test is a screening test for cervical cancer and its precursors with an inherent false-negative rate.
Store PreservCyt Solution without cytologic samples at 15°C to 30°C in the vials provided. Do not use solution beyond expiration date marked on the vial.
88142; if reviewed by pathologist add 88141
|Component Test Code*||Component Chart Name||LOINC|
|2000542||ThinPrep Pap Specimen Source|
- Pap Smear
- Pap Test
- ThinPrep Pap